Menu
← Oncology Approval Tracker
FDA DECISION ·
Cabazitaxel Injection
cabazitaxel with prednisone · Accord Healthcare
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Alternate intravenous cabazitaxel formulation, in combination with prednisone, for metastatic castration-resistant prostate cancer after a docetaxel-containing regimen.
LAMPGEN ANALYSIS
Why it matters
This 505(b)(2) approval adds a product that can be diluted for infusion without the separate predilution step used by the reference formulation.
What research teams should watch
Keep the formulation and dilution method explicit in pharmacy workflows and verify prior docetaxel exposure.
PRIMARY RECORDS